Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026

Go back to Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026
(NASDAQ: XERS) Delayed: 8.16 +0.38 (4.88%)
Previous Close $7.78    52 Week High
Open $7.68    52 Week Low
Day High $8.18    P/E N/A 
Day Low $7.69    EPS
Volume 2,341,272